blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3112343

EP3112343 - AMIDE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.02.2024
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  24.02.2023
FormerGrant of patent is intended
Status updated on  05.09.2022
FormerExamination is in progress
Status updated on  05.08.2019
FormerRequest for examination was made
Status updated on  02.12.2016
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024 [2024/26]
Applicant(s)For all designated states
Tohoku University
1-1 Katahira 2-chome Aoba-ku
Sendai-shi, Miyagi 980-8577 / JP
For all designated states
National University Corporation Gunma University
2 Aramaki-machi 4-chome
Maebashi-shi, Gunma 371-8510 / JP
For all designated states
Fuso Pharmaceutical Industries, Ltd.
7-10 Dosho-machi 1-chome Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
[2017/01]
Inventor(s)01 / KIKUCHI, Haruhisa
c/o TOHOKU UNIVERSITY
1-1 Katahira 2-chome
Aoba-ku
Sendai-shi Miyagi 980-8577 / JP
02 / OSHIMA, Yoshiteru
c/o TOHOKU UNIVERSITY
1-1 Katahira 2-chome
Aoba-ku
Sendai-shi Miyagi 980-8577 / JP
03 / HATTORI, Toshio
Takahashi-shi, Okayama 716-8508 / JP
04 / KUBOHARA, Yuzuru
Inzai-shi, Chiba 270-1695 / JP
05 / YAMADA, Osamu
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
06 / ZHANG, Jing
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
07 / MATSUSHITA, Yoshihisa
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
08 / KIDA, Shinya
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
 [2023/08]
Former [2017/01]01 / KIKUCHI, Haruhisa
c/o TOHOKU UNIVERSITY
1-1 Katahira 2-chome
Aoba-ku
Sendai-shi Miyagi 980-8577 / JP
02 / OSHIMA, Yoshiteru
c/o TOHOKU UNIVERSITY
1-1 Katahira 2-chome
Aoba-ku
Sendai-shi Miyagi 980-8577 / JP
03 / HATTORI, Toshio
c/o Kibi International University
Igamachi 8
Takahashi-shi, Okayama 7168508 / JP
04 / KUBOHARA, Yuzuru
c/o Juntendo University, 1
Hirakagakuendai 1-chome
Inzai-shi, Chiba 2701695 / JP
05 / YAMADA, Osamu
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
06 / ZHANG, Jing
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
07 / MATSUSHITA, Yoshihisa
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
08 / KIDA, Shinya
c/o Research and Development Center of
FUSO PHARMACEUTICAL INDUSTRIES LTD.
3-30 Morinomiya 2-chome
Joto-ku
Osaka-shi Osaka 536-8523 / JP
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2017/01]
Application number, filing date15755910.527.02.2015
[2017/01]
WO2015JP55873
Priority number, dateJP2014003891928.02.2014         Original published format: JP 2014038919
[2017/01]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015129860
Date:03.09.2015
Language:JA
[2015/35]
Type: A1 Application with search report 
No.:EP3112343
Date:04.01.2017
Language:EN
[2017/01]
Type: B1 Patent specification 
No.:EP3112343
Date:29.03.2023
Language:EN
[2023/13]
Search report(s)International search report - published on:JP03.09.2015
(Supplementary) European search report - dispatched on:EP28.09.2017
ClassificationIPC:C07C235/50, A61K31/166, A61K31/351, A61K31/4045, A61K31/437, A61P1/16, A61P9/10, A61P13/04, C07C233/78, A61K31/167, A61K31/381, A61K31/397, C07D211/60, C07D207/16, C07D333/38, C07D471/04, C07C237/22, C07D205/04, A61K31/445
[2022/39]
CPC:
C07C235/50 (EP,KR,US); A61K31/165 (EP,KR,US); A61K31/166 (EP,KR,US);
A61K31/167 (EP,US); A61K31/351 (EP,KR,US); A61K31/381 (EP,US);
A61K31/397 (EP,US); A61K31/40 (EP,US); A61K31/4045 (EP,US);
A61K31/437 (EP,KR,US); A61K31/4409 (EP,US); A61K31/445 (EP,US);
A61P1/16 (EP); A61P11/00 (EP); A61P13/04 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07C233/36 (EP,US); C07C233/62 (EP,US);
C07C233/78 (EP,US); C07C235/48 (EP,KR,US); C07C235/60 (EP,US);
C07C237/22 (EP,US); C07C237/34 (EP,US); C07C237/42 (EP,US);
C07D205/04 (EP,US); C07D207/16 (EP,US); C07D209/14 (EP,US);
C07D211/60 (EP,US); C07D213/81 (EP,US); C07D309/08 (EP,US);
C07D333/38 (EP,US); C07D471/04 (EP,US); C07C2601/14 (EP,US) (-)
Former IPC [2017/01]C07C235/50, A61K31/165, A61K31/166, A61K31/351, A61K31/4045, A61K31/437, A61P1/16, A61P9/10, A61P11/00, A61P13/04, A61P19/02, A61P19/10, A61P25/00, A61P29/00, A61P35/00, A61P43/00, C07C233/36, C07C233/62, C07C233/78, C07C235/48
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:AMIDDERIVATE[2017/01]
English:AMIDE DERIVATIVES[2017/01]
French:DERIVES AMIDES[2017/01]
Entry into regional phase26.09.2016Translation filed 
28.09.2016National basic fee paid 
28.09.2016Search fee paid 
28.09.2016Designation fee(s) paid 
28.09.2016Examination fee paid 
Examination procedure26.09.2016Date on which the examining division has become responsible
28.09.2016Examination requested  [2017/01]
26.04.2018Amendment by applicant (claims and/or description)
08.08.2019Despatch of a communication from the examining division (Time limit: M04)
18.12.2019Reply to a communication from the examining division
03.03.2021Despatch of a communication from the examining division (Time limit: M04)
09.07.2021Reply to a communication from the examining division
06.09.2022Communication of intention to grant the patent
16.01.2023Fee for grant paid
16.01.2023Fee for publishing/printing paid
16.01.2023Receipt of the translation of the claim(s)
Opposition(s)03.01.2024No opposition filed within time limit [2024/10]
Fees paidRenewal fee
21.02.2017Renewal fee patent year 03
23.02.2018Renewal fee patent year 04
21.02.2019Renewal fee patent year 05
20.02.2020Renewal fee patent year 06
22.02.2021Renewal fee patent year 07
21.02.2022Renewal fee patent year 08
22.02.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.03.2023
CZ29.03.2023
DK29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
IT29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
PL29.03.2023
RO29.03.2023
RS29.03.2023
SE29.03.2023
SI29.03.2023
SK29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
IS29.07.2023
PT31.07.2023
[2024/26]
Former [2024/24]AT29.03.2023
CZ29.03.2023
DK29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
PL29.03.2023
RO29.03.2023
RS29.03.2023
SE29.03.2023
SI29.03.2023
SK29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
IS29.07.2023
PT31.07.2023
Former [2024/10]AT29.03.2023
CZ29.03.2023
DK29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
PL29.03.2023
RO29.03.2023
RS29.03.2023
SE29.03.2023
SK29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
IS29.07.2023
PT31.07.2023
Former [2023/50]AT29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
PL29.03.2023
RO29.03.2023
RS29.03.2023
SE29.03.2023
SK29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
IS29.07.2023
PT31.07.2023
Former [2023/49]AT29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
RO29.03.2023
RS29.03.2023
SE29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
PT31.07.2023
Former [2023/48]AT29.03.2023
EE29.03.2023
ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
RS29.03.2023
SE29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
PT31.07.2023
Former [2023/46]ES29.03.2023
FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
RS29.03.2023
SE29.03.2023
SM29.03.2023
NO29.06.2023
GR30.06.2023
PT31.07.2023
Former [2023/38]FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
NL29.03.2023
RS29.03.2023
SE29.03.2023
NO29.06.2023
GR30.06.2023
Former [2023/37]FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
SE29.03.2023
NO29.06.2023
GR30.06.2023
Former [2023/36]FI29.03.2023
HR29.03.2023
LT29.03.2023
LV29.03.2023
RS29.03.2023
SE29.03.2023
NO29.06.2023
Former [2023/35]HR29.03.2023
LT29.03.2023
RS29.03.2023
NO29.06.2023
Former [2023/34]LT29.03.2023
RS29.03.2023
Former [2023/33]LT29.03.2023
Documents cited:Search[X]US2007093529  (FINSINGER DIRK [DE], et al) [X] 1,5-8,11-13,15 * claims 1, 17, 24, 25 ** page 48, paragraph 0285; compound 5 *;
 [XA]  - PRASAD M P ET AL, "Synthesis and insect growth regulating activity of structurally modified benzoylphenylureas", INDIAN JOURNAL OF CHEMISTRY, SECTION B, COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (C S I R), DE, (19901001), vol. Section B, no. 1990, ISSN 0376-4699, pages 951 - 953, XP009500217 [X] 1,3,5-8 * page 952; table 1; compounds BGA-10, BGA-12 * [A] 2,4,9-15
International search[X]JPS49101348  (Suntory Ltd.) [X] 1, 2, 7, 11 * , page 1, lower right column; example 2 (Family: none) *;
 [X]JP2003128639  (SANKYO CO) [X] 1, 4, 5, 7, 8, 11-13, 15 * , claims; examples 87, 88 (Family: none) *;
 [X]WO2006016218  (PFIZER JAPAN INC [JP], et al) [X] 1, 2, 7, 11-15 * , examples 5, 6, 16; claims 1, 6, 13 (Family: none) *;
 [X]WO2007003934  (STERIX LTD [GB], et al) [X] 1, 4, 6-9, 11-13, 15 * , examples; claims; particularly, STX1623, 1629 to 1631, 1762, 1779, 1859 & US 2009/0023710 A1 & EP 1960347 A1 & CA 2613226 A *;
 [X]JP2007506777  (Exelixis, Inc.) [X] 1, 4, 7, 8, 11-13, 15 * , claims; examples; particularly, compound 60 & WO 2005/030140 A2 & CA 2537812 A & AU 2004275842 A & EP 1673085 A1 & US 2007/0054928 A1 *;
 [X]WO2010028192  (REPLIGEN CORP [US], et al) [X] 1, 3-5, 7, 8, 11-13, 15 * , page 136, R124; page 137, R127; page 189, R50; claims & US 2012/0094971 A1 & EP 2330894 A1 & AU 2009289649 A & CA 2735593 A *;
 [X]JP2010540633  (Lixte Biotechnology, Inc.) [X] 1, 4, 5, 7, 8, 11-13, 15 * , claims; examples & US 2009/0143445 A1 & US 2012/0178783 A1 & WO 2009/045440 A1 & EP 2200439 A1 & AU 2008307541 A & CA 2700857 A & CN 101854804 A *;
 [X]WO2011035143  (UNIV MICHIGAN [US], et al) [X] 1, 4, 5, 7, 8, 11-13, 15 * , pages 88 to 89; particularly, compounds 13, 20, 21; claims & US 2012/0252792 A1 *;
 [X]WO2011032291  (ZALICUS PHARMACEUTICALS LTD [CA], et al) [X] 1, 4, 7-9, 11 * , examples; claims; particularly, compound 18 & US 2012/0220564 A1 & CA 2771612 A *;
 [X]JP2011512321  (Acucela Inc.) [X] 1, 2, 7, 11 * , paragraph [0520], compound 52 & US 2009/0326074 A1 & WO 2009/045479 A1 & EP 2091955 A1 & KR 10-2010-0066577 A & CN 101889017 A *;
 [X]CN102320989  (UNIV PLA 2ND MILITARY MEDICAL) [X] 1, 4, 5, 7, 11-13, 15 * , claims; examples; particularly, compounds (6), (7) (Family: none) *;
 [X]JP2012505855  (Universite Libre de Bruxelles) [X] 1, 4, 5, 7, 11-13, 15 * , claims; examples; particularly, compounds DLT35, 36, 44, 57 & US 2011/0280940 A1 & WO 2010/043631 A1 & EP 2367545 A1 & AU 2009305450 A & CA 2737855 A *;
 [X]WO2013063492  (UNIV TEXAS [US], et al) [X] 1-4, 7, 11-15 * , paragraphs [0485], [0488], [0507], [0519], [0531]; claims 1, 3, 7, 81 & US 2013/0129812 A1 & EP 2771341 A1 & CA 2853729 A *;
 [X]  - HARUHISA KIKUCHI et al., "Isolation and Synthesis of a New Aromatic Compound, Brefelamide, from Dictyostelium Cellular Slime Molds and Its Inhibitory Effect on the Proliferation of Astrocytoma Cells", THE JOURNAL OF ORGANIC CHEMISTRY, (20050000), vol. 70, no. 22, pages 8854 - 8858, XP 055221527 [X] 1-7, 11-15 * , particularly, page 8856, compounds 1, 9, 10, 12 *
 [X]  - ANTONIO ENTRENA et al., "Kynurenamines as Neural Nitric Oxide Synthase Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, (20050000), vol. 48, no. 26, pages 8174 - 8181, XP 055221529 [X] 1-4, 7, 11 * , particularly, pages 8175 to 8176, compounds 4a to 4i *
 [X]  - BYOUNGHO MOON et al., "Structure and Bioactivity of Erebusinone, a Pigment from the Antarctic Sponge Isodictya erinacea", TETRAHEDRON, (20000000), vol. 56, no. 46, pages 9057 - 9062, XP 004238563 [X] 1, 2, 7, 11 * , particularly, Figure 2, compounds 1, 4 *
 [XP]  - MARLENE T. BARHO et al., "N-Acyl Derivatives of 4-Phenoxyaniline as Neuroprotective Agents", CHEMMEDCHEM, (20141000), vol. 9, no. 10, pages 2260 - 2273, XP 055221531 [XP] 1, 4-8, 11 * , particularly, Table 3, compounds 23, 25, 27 *
 [X]  - EVGENIJA DJURENDIC et al., "Synthesis and biological evaluation of some new 2-oxazoline and salicylic acid derivatives", ARKIVOC, (20110000), pages 83 - 102, XP 055137317 [X] 1, 4, 7, 11-13, 15 * , particularly, Table 1, compounds 5d, 8c, page 91 *
 [PX]  - SHIN'YA MURASE et al., "Saibosei Nenkin Yurai Kagobutsu brefelamide to sono Yudotai no Osteopontin Hatsugen Yokusei Sayo", The Pharmaceutical Society of Japan Tohoku Shibu Taikai Koen Yoshishu, (20141005), vol. 53, page 30, XP008184695 [PX] 1-7, 10-15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.